. Author manuscript; available in PMC: 2016 May 18.
Published in final edited form as: Oncogene. 2015 Apr 20;35(5):537–548. doi: 10.1038/onc.2015.125
Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms
Figure 3.
Merlin inhibits PI3K/mTORC1/Akt signaling pathways.